Neuroglee Connect
Commercial- Indications
- Mild cognitive impairment, Dementia
Company intelligence / Profile preview
Neuroglee Health delivers evidence-based, AI-powered digital therapeutics and virtual care solutions for patients with mild cognitive impairment and dementia. Its flagship product, Neuroglee Connect™, combines cognitive stimulation exercises with behavioral health coaching via a mobile app and remote physician-led team. The company has demonstrated improved patient engagement, reduced caregiver burden, and positive clinical outcomes in early deployments. It partners with major healthcare organizations—including Mayo Clinic—and participates in the CMS GUIDE Model to expand access to value-based dementia care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuroglee Health.